Our results are in agreement with such studies and indicate that the expression of the two major subunits of the ATP1 gene, namely the ATP1A1 and the ATP1B1, are downregulated in the PBMCs of our COVID-19 patients with low FT3 serum values, as compared to those with normal FT3 serum values. This evidence concerns the gene ATP1A1 and COVID-19.